Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

June 30, 2007

Conditions
Chronic Heart Failure
Interventions
DRUG

Irbesartan

up-titration over 4 weeks to target dose 300 mg od

Trial Locations (1)

Unknown

Applied Cachexia Research, Cardiology Dept. Charite Medical School, Virchow Klinikum, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER